financetom
Business
financetom
/
Business
/
Shell Boosts LNG Production Forecast As Refining Margins Surge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shell Boosts LNG Production Forecast As Refining Margins Surge
Oct 7, 2025 3:24 AM

Shell plc ( SHEL ) shares were trading higher premarket on Tuesday after the company revised its third-quarter outlook.

The oil giant trimmed the guidance for production at Integrated Gas to around 910 and 950 thousand boe/d (versus the prior outlook of 910 – 970 thousand boe/d).

The company expects Trading & Optimisation to be significantly higher than the second quarter of fiscal 2025 in the Integrated Gas segment.

Also Read: Carney Cuts The Red Tape, Unveils Over $43 Billion In Flagship Projects

On the other hand, Shell raised the LNG liquefaction volumes forecast to 7.0 – 7.4 million metric tons from a previous guidance of 6.7 million – 7.3 million metric tons.

Shell tightened the outlook for the Upstream segment to about 1,790 – 1,890 thousand boe/d (versus the earlier outlook of 1,700 – 1,900 thousand boe/d) and expects adjusted earnings to take a $200 – $400 million hit from the rebalancing of participation interests in Brazil.

The company now anticipates refinery utilization of around 94% – 98% (versus prior outlook of 88% – 96%). It sees a refining margin of $11.6 per barrel in the quarter, higher than $8.9 per barrel in the second quarter.

On the other hand, Shell expects chemical manufacturing plant utilization of 79% – 83% (versus earlier guidance of 78% – 86%), with the chemicals sub-segment to witness an adjusted loss in the third quarter.

The company now projects Marketing sales volumes of around 2,650 – 3,050 thousand b/d (versus earlier guidance of 2,600 – 3,100 thousand b/d).

The company expects non-cash post-tax impairments & provisions of around $600 million in the Marketing segment in the third quarter, following the cancellation of its Rotterdam biofuels project.

Last month, Shell’s subsidiary opted to halt plans to resume construction of its biofuels facility at the Shell Energy and Chemicals Park in Rotterdam.

As per Reuters, this brings total impairments and provisions related to the venture to $1.4 billion.

Notably, in July, Shell had temporarily suspended on-site construction at its 820,000 tonnes per year biofuels facility in Shell Energy and Chemicals Park Rotterdam, Netherlands.

Investors can gain exposure to the stock via Precidian ETFs Trust Shell plc ADRhedged and First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF .

Price Action: SHEL shares were trading higher by 0.92% to $74.95 premarket at last check Tuesday.

Read Next:

Hungary Deepens Energy Ties With Shell As Russian Reliance Persists

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
West Red Lake Gold Reports PFS Highlights For the Madsen Mine Ahead of Restarting Production
West Red Lake Gold Reports PFS Highlights For the Madsen Mine Ahead of Restarting Production
Jan 7, 2025
11:17 AM EST, 01/07/2025 (MT Newswires) -- West Red Lake Gold Mines ( WRLGF ) on Tuesday released a pre-feasibility study (PFS) ahead of the imminent restart of its Madsen Mine project in the Red Lake Gold District of northwestern Ontario. The mine is expected to restart production in the second quarter of this year. Highlights for the project include...
Point72 kicks off new private credit strategy, statement shows
Point72 kicks off new private credit strategy, statement shows
Jan 7, 2025
NEW YORK (Reuters) - Point72 Asset Management has hired Todd Hirsch, a former senior managing director at Blackstone, to head a new strategy focused on the fast-growing private credit business, according to an internal statement seen by Reuters. Steve Cohen, the firm's founder, said in the statement that demand for private credit continues to exceed supply, creating a good environment...
Stoke Therapeutics Reports Alignment With Regulators for Dravet Syndrome Trial
Stoke Therapeutics Reports Alignment With Regulators for Dravet Syndrome Trial
Jan 7, 2025
11:19 AM EST, 01/07/2025 (MT Newswires) -- Stoke Therapeutics ( STOK ) said Tuesday it has reached alignment with global regulatory agencies on the design of its phase 3 trial of zorevunersen to treat Dravet syndrome. The company said it has finalized the trial protocol after interactions with the US Food and Drug Administration, the EU's European Medicines Agency, and...
Why Amesite (AMST) Shares Are Falling
Why Amesite (AMST) Shares Are Falling
Jan 7, 2025
Amesite Inc ( AMST ) shares are trading lower by 28.3% to $2.90 during Tuesday’s session after the company announced a $3.6 million public offering of 1.2 million shares. Company officers and directors are contributing $1.26 million in subscriptions. The offering, led by Laidlaw & Company and Craft Capital Management, is set to close on January 8, pending customary conditions. Proceeds will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved